... possible influence of gender on the clinical status and diseaseactivity measures of RA appears to be of value Therefore, we explored possible associations of gender and diseaseactivity measures, ... sites in 25 countries as of April 2008 Gender differences were analyzed for American College of Rheumatology Core Data Set measures ofdisease activity, DAS28 (disease activity score using 28 ... cohort, RA diseaseactivity measures appear to be worse in women than in men However, most of the gender differences in RA diseaseactivity may originate from the measures ofdiseaseactivity rather...
... Evaluation of the efficacy of long-term therapy shows that, after years of infliximab therapy, the majority of patients had a low level ofdiseaseactivity and that approximately half of the patients ... at each of weeks 0, 6, 14, and 22: 28 and 66/68 swollen/tender joint counts, ESR, CRP, HAQ, physician's global assessment ofdisease activity, patient's global assessment ofdisease activity, ... infliximab at year 4, 62% had a low level ofdisease activity, as defined by a DAS28 score of less than 3.2 Nearly half (49.5%) of these patients had minimal diseaseactivity (DAS28 less than 2.85 or...
... possible influence of gender on the clinical status and diseaseactivity measures of RA appears to be of value Therefore, we explored possible associations of gender and diseaseactivity measures, ... sites in 25 countries as of April 2008 Gender differences were analyzed for American College of Rheumatology Core Data Set measures ofdisease activity, DAS28 (disease activity score using 28 ... cohort, RA diseaseactivity measures appear to be worse in women than in men However, most of the gender differences in RA diseaseactivity may originate from the measures ofdiseaseactivity rather...
... for RA patients and leads to improved control ofdiseaseactivity Thus, therapeutic drug monitoring of infliximab may improve the control ofdiseaseactivity in RA Competing interests DM and J-PV ... conventional laboratory marker testing Control ofdiseaseactivity was categorized as 'optimal', 'acceptable', or 'inadequate' by a combination ofdiseaseactivity score for 28 joints (DAS28) and physician ... therapeutic strategy and improves the control ofdiseaseactivity in RA The secondary objective was to study whether this improvement in control ofdiseaseactivity is related to changes in infliximab...
... may not be representative of functional extracellular proteolytic activity in vivo In the past five years, three different concepts ofbiomarkersof protease activityof extracellular matrix degradation ... FEV1, Kco and baseline value of each of the biomarkers was assessed by the Spearman's rank correlation coefficient Results Analysis of change over time of any of the three biomarkers for a given treatment ... 15 to day 44 for each of the treatment groups was calculated for each of the three different biomarkers To test for a treatment effect of hyaluronic acid on each of the biomarkers, the differences...
... patient's UC activity We expect that the future combination of improved survey questions for UC activity assessment and biomarkersof UC inflammation will result in better assessment ofdiseaseactivity ... unresponsive symptom domains Discussion Conventional assessment ofdiseaseactivity in ulcerative colitis is done using any one of a number ofdiseaseactivity indices that measure various symptoms and signs ... investigation and validation as representative of UC diseaseactivity This will be undertaken in develop- ment of questions for assessment ofdiseaseactivity based on these frequent and responsive...
... signs ofdiseaseactivity defined as a SLEDAI peak score of at least (median 16) for a median time of 16.1 months (range 5–27 months) The term ‘flare’ was used to describe the time-point of highest ... g of albumin per 24 hours), haematuria and/or cellular casts by urine analyses at some time during the study On the occasion of each blood sampling, diseaseactivity was assessed by the SLE disease ... markers ofdiseaseactivity in rheumatoid arthritis than in SLE [15] Relations between anti-C-reactive protein autoantibody (anti-CRP) levels and systemic lupus erythematosus disease activity...
... histopathological features in SpA reflect global diseaseactivity independently of SpA subtype, disease duration, and treatment Prediction of global diseaseactivity in individual SpA samples Since the ... rate (ESR) of 28 ± 24 mm/hour The mean duration ofdisease was 5.5 ± 5.4 years, and 23 of the 82 patients were being treated with a disease- modifying antirheumatic drug (DMARD); none of the patients ... chance of being real) were considered significant Finally, histological parameters that not only are correlated with diseaseactivity but also contribute significantly to the prediction of the disease...
... Changes in (a) DiseaseActivity Score (DAS)28, (b) Simplified DiseaseActivity Index (SDAI) and (c) Clinical DiseaseActivity Index (CDAI) in relation to the achieved American College of Rheumatology ... aspects of validity of the CDAI [29]: correlational validity refers to comparison with other measures ofdisease activity; discriminant validity in this setting relates to the correlation of changes ... in the assessment of RA diseaseactivity [38] On the other hand, joint counts are also required for other composite diseaseactivity scores, and the CDAI allows elimination of at least one variable...
... (hydrochloroquine 200 to 400 mg/day) For each patient, diseaseactivity and disease- related damage were assessed at the time of blood donation using the SLE DiseaseActivity Index 2000 (SLEDAI-2K) [16] and ... Correlation of chemokine score with disease activity, as assessed using SLEDAI-2K and hypocomplementaemia To investigate whether the expression of IFN-inducible chemokines might be related to SLE disease ... be related to SLE disease activity, we compared chemokine scores in SLE patients with different levels ofdisease activity, as assessed using SLEDAI-2K and the level of complement C3 SLE patients...
... Ankylosing Correlationand clinical index ofdisease T Lymphocyte Antigen- 4Spond(sCTLA-4) and clinical index ofdiseaseactivity Bath Ankylosing Spondylitis DiseaseActivity Index in 165 patients with ... clinical index ofdiseaseactivity SLEDAI in one study [16], but not in a second [15] In systemic sclerosis, patients exhibited high levels of serum sCTLA-4 that correlated with diseaseactivity [16] ... with diseaseactivity These high levels of circulating sCTLA-4 in SpA were not explained by altered intracellular expression of CTLA-4, but by a preferential expression of the spliced form of CTLA-4...
... interquartile ranges In spite of the high number of patients and because of the uneven frequency of early RA and UA data, we used nonparametric tests for statistical analysis of continuous variables ... determine whether markers of B-cell activation can serve as predictive factors of long-term clinical activity The main limitations of this study were the short duration of follow-up (1 year) so ... [21,22] The originality of the present study is to also assess markers of activation of alloreactive B cells in early arthritis, such as total levels of immunoglobulins, FLCs of immunoglobulins,...
... [7] – were used in the long-term follow-up of adalimumab treatment The Bath AS DiseaseActivity Index (BASDAI) was included as a measure ofdiseaseactivity [36] Available online http://arthritis-research.com/content/11/4/R124 ... quality of life Recent research has suggested that the ASQOL is a psychometrically sound and responsive measure of disease- specific quality of life in patients with AS and differences of one to ... availability of TNF antagonists (infliximab, adalimumab, and etanercept), AS patients have experienced improvements in the signs and symptoms of their disease In clinical trials of TNF antagonists,...
... Correlation of MP level with diseaseactivityof pSS and other AIDs As MPs can reflect the state of cellular stimulation, we hypothesized that the level of MPs could be associated with AID activity ... state of cell activation in these diseases However, because the level of MPs increases less in patients with more severe disease, the interest of using MP levels for monitoring diseaseactivity ... We found no association or correlation of level of these biomarkers with diseaseactivity Discussion In the present study, we investigated the plasma level of circulating MPs in patients with the...
... dissociation However, comparing the changes in diseaseactivity and response to tocilizumab using the Clinical DiseaseActivity Index (CDAI) and Simplified DiseaseActivity Index (SDAI) in three clinical ... efficacy of etanercept when infliximab had been ineffective Twenty-five RA patients were enrolled; 18 of them discontinued infliximab because of lack of efficacy, and 22 completed 12 weeks of etanercept ... 62% of infliximab-treated patients achieved an ACR20 response compared with 29% of etanercept-treated patients, and 30.7% of group achieved ACR50 compared with 14.3% of group DAS28 values of Available...
... detected in serum samples from these mice B Reduced diseaseactivity in adeno IL-10 gene transfected mice A combinatorial index of disease, or disease acticvity index (DAI), defined as stool blood, ... benefit of adenoviral gene delivery We found that compared to adeno-null or untreated mice, adenoviral IL-10 gene transfection after induction of clinical disease reversed the course of the disease ... 7–10 when adenoviral administration of IL-10 was given on day Diseaseactivity in control mice continued at the same level as the adeno-null mice on DSS Diseaseactivity was slightly higher in adeno-null...
... evaluation ofdiseaseactivity and response to therapy in lupus nephritis Distinction ofdiseaseactivity from organ damage in SLE remains a challenge Indirect assessment ofdiseaseactivity such ... Microscopic examination of a kidney biopsy, with classification and estimation of indices of renal diseaseactivity and chronicity, today offers the best possibility to estimate renal disease and its ... study also confirms previous findings of associations between anti-CRP and lupus diseaseactivity as assessed by common clinical and laboratory diseaseactivity measures, such as complement and...
... diseaseactivity (3.2 5.1) The DAS28 specifies the diseaseactivity measuring the number of tender and swollen joints, the ESR and VAS of general ... University of Wuerzburg We differentiated the patients according to EULAR criteria in patients in remission (DAS28 ≤2.6), patients with low diseaseactivity (2.6
... there were no correlations to disease parameters such as diseaseactivity as measured by the diseaseactivity score (DAS), the presence and level of rheumatoid factors of IgA, IgM, or IgG class or ... phagocytosis of apoptotic cells and it is noteworthy that the plasma levels of sMer did not correlate with diseaseactivity [15] Moreover, in most of the patients, the plasma concentrations of sMer ... data suggest that shedding of Mer is an active process in the SLE disease process and that the levels of sMer reflect diseaseactivity Abbreviations ACR: American College of Rheumatology; ARA: American...